Given the strong correlation between diabetes and cardiac fibrosis [13], [14], [15], [16], we explored whether BMPC therapy (via HGF secretion) inhibits miR-155 expression and prevents cardiac fibrosis in the infarcted hearts of diabetic mice. The gene discussed is HGF; the disease is diabetes mellitus.